Synthesis of cell-penetrating conjugates of calpain activator peptides

Bioconjugate Chemistry

Volumn 18, Issue 1, 2007, Pages 130-137

  Bánoczi, Zoltán ^a   Tantos, Ágnes ^b   Farkas, Attila ^b   Tompa, Péter ^b   Friedrich, Péter ^b   Hudecz, Ferenc ^a,c  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMICAL ACTIVATION; COVALENT BONDS; CYTOLOGY; ENZYMES; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

CALPAINS; CALPASTATIN; DISULPHIDE BONDS; GROUP OF CELLS; LIVING CELL; OVEREXPRESSIONS; PENETRATIN; PROTEOLYTIC ENZYME; THIOETHER BONDS; UNDERLYING FACTORS;

PEPTIDES;

4 (7 HYDROXYCOUMARYL)ACETIC ACID; CALPAIN; CALPASTATIN; CARBOXYFLUORESCEIN; CELL PENETRATING PEPTIDE; COUMARIN DERIVATIVE; PENETRATIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STRAIN COS7; CONTROLLED STUDY; FLOW CYTOMETRY; INTERNALIZATION; MASS SPECTROMETRY; NONHUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE SYNTHESIS;

EID: 33846436426     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0601976     Document Type: Article

References (36)

1. Sorimachi, H., Ishiura, S., and Suzuki, K. (1997) Structure and physiological function of calpains. Biochem. J. 328, 721-732.
2. Sorimachi, H., and Suzuki, K. (2001) The structure of calpain. J. Biochem. (Tokyo) 129, 653-664.
3. Goll, D. E., Thompson, V., Li, F. H., Wei, W., and Cong, J. (2003) The calpain system. Physiol. Rev. 83, 731-801.
4. Glading, A., Lauffenburger, D. A., and Wells, A. (2002) Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 12, 46-54.
5. Sato, K., and Kawashima, S. (2001) Calpain function in the modulation of signal transduction molecules. Biol. Chem. 382, 743-751.
6. Rutledge, T. W., and Whiteheart, S. W. (2002) SNAP-23 is a target for calpain cleavage in activated platelets. J. Biol. Chem. 277, 37009-37015.
7. Franco, S. J., and Huttenlocher, A. (2005) Regulating cell migration: calpains make the cut. J. Cell Sci. 118, 3829-3838.
8. Huang, Y., and Wang, K. K. (2001) The calpain family and human disease. Trends Mol. Med. 7, 355-362.
9. Baki, A., Tompa, P., Alexa, A., Molnar, O., and Friedrich, P. (1996) Autolysis parallels activation of μ-calpain. Biochem. J. 318, 897-901.
10. Maki, M., Takano, E., Mori, H., Sato, A., Murachi, T., and Hatanaka, M. (1987) All 4 internally repetitive domains of pig calpastatin posses inhibitory activities against calpain-I and calpain-II. FEBS Lett. 223, 174-180.
11. Maki, M., Bagaci, H., Hamaguchi, K., Ueda, M., Murachi, T., and Hatanaka, M. (1989) Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866-18869.
12. Takano, E., Ma, H., Yang, H. Q., Maki, M., and Hatanaka, M. (1995) Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains. FEBS Lett. 362, 93-97.
13. Ma, H., Yang, H. Q., Takano, E., Hatanaka, M., and Maki, M. (1994) Amino-terminal conserved region in proteinase inhibitor domain of calpastatin potentiates its calpain inhibitory activity by interacting with calmodulin-like domain of the proteinase. J. Biol. Chem. 269, 24430-24436.
14. Maki, M., Takano, E., Osawa, T., Ooi, T., Murachi, T., and Hatanaka, M. (1988) Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli. J. Biol. Chem. 263, 10254-10261.
15. Tompa, P., Mucsi, Z., Orosz, Gy., and Friedrich, P. (2002) Calpastatin subdomains A and C are activators of calpain. J. Biol. Chem. 277, 9022-9026.
16. Wang, K. K., and Yuen, P. W. (1994) Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. Sci. 15, 412-419.
17. Donkor, I. O. (2000) A survey of calpain inhibitors. Curr. Med. Chem. 7, 1171-1188.
18. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
19. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human munodeficiency virus Tat trans-activator protein. Cell 55, 1179-1186.
20. Joliot, A., Pernelle, C., Deagostini-Bazin, H., and Prochiantz, A. (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88, 1864-1868.
21. Hudecz, F., Bánóczi, Z., and Csík, G. (2005) Medium-sized peptides as built in carriers for biologically active compounds. Med. Res. Rev. 25, 679-736.
22. Croce, K., Flaumenhaft, R., Riversi, M., Furie, B., Furie, B. C., Herman, I. M., and Potter, D. (1999) A. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J. Biol. Chem. 274, 36321-36327.
23. Wu, H. Y., Tomizawa, K., Matsushita, M., Lu, Y. F., Li, S. T., and Matsui, H. (2003) Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain. Neurosci. Res. 47, 131-135.
24. Gil-Parrado, S., Assfalg-Machleidt, I., Fiorino, F., Deluca, D., Pfeiler, D., Schaschke, N., Moroder, L., and Machleidt, W. (2003) Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. Biol. Chem. 384, 395-402.
25. Sengoku, T., Bondada, V., Hassane, D., Dubal, S., and Geddes, J. W. (2004) Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity. Exp. Neural. 188, 161-170.
26. Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P. I. (1970) Color test of detection of free amino groups in the solid phase synthesis of peptides. Anal. Biochem. 34, 595-598.
27. Kaiser, E., Bossinger, C. D., Colescott, R. L., and Olsen, D. B. (1980) Color test for terminal prolyl residues in the solid phase synthesis of peptides. Anal. Chim. Acta 118, 149-151.
28. Mezö, G., de Oliveira, E., Krikorian, D., Feijlbrief, M., Jakab, A., Tsikaris, V., Sakarellos, C., Welling-Wester, S., Andreu, D., and Hudecz, F. (2003) Synthesis and comparision of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjugate Chem. 14, 1260-1269.
29. Tompa, P., Buzder-Lantos, P., Tantos, A., Farkas, A., Szilagyi, A., Banoczi, Z., Hudecz, F., and Friedrich, P. (2004) On the sequential determinants of calpain cleavage. J. Biol. Chem. 279, 20775-20785.
30. Saito, G., Swanson, J. A., and Lee, K. D. (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Delivery Rev. 55, 199-215.
31. Matsueda, R., and Walter, R. (1980) 3-Nitro-2-piridinesulfenyl (Npys) group. Int. J. Pept. Protein Res. 16, 392-401.
32. Matsueda, R., Kimura, T., Kaiser, E. T., and Matsueda, G. R. (1981) 3-Nitro-2-pyridinesulfenyl group for protection and activation of the thiol function of cystein. Chem. Lett. 737-740.
33. Mezö, G., Mihala, N., Andreu, D., and Hudecz, F. (2000) Conjugation of epitope peptides to branched chain polypeptides via Cys(Npys). Bioconjugate Chem. 11, 484-491.
34. Ivanov, B. B., and Robey, A. F. (1996) Effective use of free thiols as scavengers for HF cocktails to deprotect bromo- and chloroacetyl synthetic peptides. Pept. Res. 9, 305-307.
35. Robey, A. F., and Fields, L. R. (1989) Automated synthesis of N-bromoacethyl-modified peptides for preparation of synthetic peptide polymers, peptide-protein conjugates and cyclic peptides. Anal. Biochem. 177, 373-377.
36. Mezö, G., Manea, M., Jakab, A., Kapuvári, B., Bösze, Sz., Schlosser, G., Przybylski, M., and Hudecz, F. (2004) Synthesis and structural characterization of bioactive peptide conjugates using thioether linkage approaches. J. Pept. Sci. 10, 701-713.